Early Prediction of Nonprogression in Advanced Non-Small-Cell Lung Cancer Treated With Erlotinib By Using [(18)F]Fluorodeoxyglucose and [(18)F]Fluorothymidine Positron Emission Tomography

T. Zander, M. Scheffler, L. Nogova, C. Kobe, W. Engel-Riedel, M. Hellmich, I. Papachristou, K. Toepelt, A. Draube, L. Heukamp, R. Buettner, Y.D. Ko, R.T. Ullrich, E.F. Smit, R. Boellaard, A.A. Lammertsma, M. Hallek, A.H. Jacobs, A. Schlesinger, K. SchulteS. Querings, E. Stoelben, B. Neumaier, R.K. Thomas, M. Dietlein, J. Wolf

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1701-1708
JournalJournal of Clinical Oncology
Volume29
Issue number13
DOIs
Publication statusPublished - 2011

Cite this